Compositions and methods for darkening the skin

Details Compositions and methods for darkening the skin Compositions and methods for darkening the skin

2006-04-11

2006-04-11

Tate, Christopher R. (Department: 1654)

Drug, bio-affecting and body treating compositions

Topical sun or radiation screening, or tanning preparations

Reexamination Certificate

active

07025951

ABSTRACT:
The present invention relates to a method of darkening the skin by topically applying to the skin a peptide and compositions containing such peptides.

REFERENCES:
patent: 3755560 (1973-08-01), Dickert et al.
patent: 4254105 (1981-03-01), Fukuda
patent: 4421769 (1983-12-01), Dixon et al.
patent: 4960764 (1990-10-01), Figueroa, Jr. et al.
patent: 5216116 (1993-06-01), Pawelek
patent: 5218079 (1993-06-01), Pawelek et al.
patent: 5225435 (1993-07-01), Pawelek et al.
patent: 5227459 (1993-07-01), Pawelek et al.
patent: 5260065 (1993-11-01), Mathur et al.
patent: 5384116 (1995-01-01), Pawelek et al.
patent: 5618519 (1997-04-01), Pawelek et al.
patent: 5744125 (1998-04-01), Pawelek et al.
patent: 5763575 (1998-06-01), Sundelin et al.
patent: 6245342 (2001-06-01), Golz-Berner
patent: WO 98/25584 (1998-06-01), None
patent: WO 96/31194 (1998-10-01), None
patent: WO 99/04752 (1999-02-01), None
patent: WO 99/37279 (1999-07-01), None
patent: WO 00/15188 (2000-03-01), None
patent: WO 00/62743 (2000-10-01), None
Michel Pruntaras, “Melanocytes, Melanogenesis and Inflammation”, International Journal of Dermatology, vol 25, No. 10, Dec. 1986, pp 624-628.
PCT International Search Report Nov. 10, 2003 for corresponding PCT Application PCT/US03/19234.
John A. Wenninger, G.N. McEwen, Jr., International Cosmetic Ingredient Dictionary and Handbook, (1997), 1612-1613, 1626, 1654-1661, 1673-1686, 1693-1697 ,Seventh Edition 1997, vol. 2, The Cosmetic, Toiletry, and Fragrance Association, Washington, DC.
Miklos Bodanszky, In Search of new methods in peptide synthesis, (1985) 449-474, International J. Peptide Protein Research 25, Munksgaard International Pubblishers Ltd. Copenhagen Denmark.
Michael Mezei, Vijeyalakshmi Gulasekharam, Liposomes-A selective drug delivery system for the topical route of administration: gel dosage form, (1982) Journal Pharm. Pharacol. 34:473-474.
Susan M. Niemiec, Chandrasekharan Ramachandran, Norman Weiner, Influence of Nonionic Liposomal Composition on Topical Delivery of Peptide Drugs Into Pilosebaceous Units: An In Vivo Study Using the Hamster Ear Model, (1995), Pharmaceutical Research, vol. 12, No. 8: 1184-1188, Plenum Publishing Corporation.
Petra Boukamp, Rule T. Petrussevska, Dirk Breitkreutz, Jurgen Hornung, Alex Markham, Norbert E. Fusenig, Normal Keratinization in a Spontaneously Immortalized Aneupiold Human Keratinocyte Cell Line, (1988). The Journal of Cell Biology, vol. 106:761-771, The Rockefeller University Press.
M. Seiberg, C. Paine, E. Sharlow, P. Andrade-Gordon, M. Costanzo, M. Eisinger, S. S. Shapiro, The Protease-Activated Receptor 2 Regulates Pigmentation via Keratinocyte-Melanocyte Interactions, (2000), Experimental Cell Research, 25-32, Academic Press.
E.R. Sharlow, C.S. Paine, L. Babiarz, M. Eisinger, S. Shapiro, M. Seiberg, The protease-activated receptor-2 upregulates keratinocyte phagocytosis (2000)Journal of Cell Science 113:3093-3101, The Company of Biologists Limited.
Miri Seiberg, Christine Paine, Elizabeth Sharlow, Patricia Andrade-Gordon, Michael Constanzo, Magdelena Eisinger and Stanley S. Shapiro, Inhibition of Melanosome Transfer Results in Skin Lightening, (2000), The Journal of Investigative Dermatology, vol. 115, No.2:162-167, The Society of Investigative Dermatology, Inc.
Dezna C. Sheehan, Barbara B. Hrapchak, Theory and practice of Histotechnology, (1980), 223,224,277 Second Edition, Battle Press.
D.D. Breimer, P. Speiser, Liposomes as a Skin Drug Delivery System, Topics in Pharmaceutical Sciences (1985), Elsevier Science Publishers, New York, pp. 345-358.
McCutcheon's Emulsifiers & Detergents, 1986 North American Edition, pp. 317-324.
Cosmetics Science and Technology, 1972 John Wiley & Sons, Inc. Canada, pp. 32-43, 72-73, 443-465.
V. Santagada, G. Caliendo, B. Severino, E. Perissutti, F. Fiorino, C. Cicala, V. Defilippis, G. Cirino, Minimal Structural Requirements for Agonist Activity of PAR-2 Activating Peptides, Bioorganic & medicinal Chemistry Letters 12, (2002), 21-24. Elsevier Science Ltd.
Johnson & Johnson Consumer Companies, Inc. pending U.S. Appl. No. 09/862,145.
Johnson & Johnson Consumer Companies, Inc. pending U.S. Appl. No. 09/861,972.
Johnson & Johnson Consumer Companies, Inc. pending U.S. Appl. No. 09/861,973.
Johnson & Johnson Consumer Companies, Inc. pending U.S. Appl. No. 60/368,298.

Affiliated with

Also associated with

Rating

Compositions and methods for darkening the skin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for darkening the skin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for darkening the skin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3547994